Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate experimental medication BMS-986277 given alone and in combination with Nivolumab in patients with epithelial cancers.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer
NCT01109420 · Non-Medullary Thyroid Cancer
NCT06043817 · Non-Small Cell Lung Cancer, NSCLC, and more
NCT06340568 · Endometrial Cancer
Sanford Research
Sioux Falls, South Dakota
Local Institution
Ottawa, Ontario
Princess Margaret Cancer Centre
Toronto, Ontario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions